Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

ClinicalTrials.gov ID

NCT07558564

Lead Sponsor

ReSport ClinicOTHER

Overall Status

Recruiting

Study Type

Observational

Enrollment

2,000Estimated

Last Update Posted

Apr 30, 2026Actual

Start Date

Apr 2026Estimated

Primary Completion Date

Mar 2028Estimated

Completion Date

Mar 2028Estimated

Official Title

Multicenter Real-World Evidence (RWE) Study: Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

Brief Summary

This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.

• Patellar Tendinopathy
• Achilles Tendinopathy (AT)
• Epicondylitis, Lateral
• Plantar Fasciitis, Chronic

• Platelet rich plasma (PRP)

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks)
• Age >18 years
• Provision of written informed consent
• Willingness and ability to complete follow-up assessments for 12 months

Exclusion Criteria:

• Surgical treatment of the affected tendon within the previous 6 months
• Corticosteroid injection within the last month
• Systemic inflammatory disease (e.g., rheumatoid arthritis)
• Coagulopathies or ongoing anticoagulant therapy
• Complete blood count showing a platelet concentration <100 × 10⁹/L (to exclude patients with potential thrombocytopenia)
• Pregnancy or breastfeeding

Observational Model

Cohort

Time Perspective

Prospective

Lead Sponsor

ReSport ClinicOTHER

Collaborators

BioSmartDataOTHER

info@institutocugat.com+34 938 34 64 50

abat@resportclinic.com+34 932 77 87 09

madrid@ripollydeprado.com+34 91 457 78 02

pacientes@hospitalmiks.com

• Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

  NCT01843504

  CompletedInterventionalPhase 2Updated Jul 22, 2026
• Platelet-Rich Plasma Therapy for Patellar Tendinopathy

  NCT03136965

  CompletedInterventionalPhase 2Updated Oct 26, 2023
• Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma

  NCT01406821

  CompletedInterventionalNot ApplicableUpdated Mar 29, 2019
• Leukocyte-Poor Platelet-Rich Plasma Reduces Pain Symptoms in the Treatment of the Lateral Epicondylitis

  NCT06854666

  CompletedInterventionalNot ApplicableUpdated Mar 3, 2025
• The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial

  NCT00761423

  CompletedInterventionalPhase 4Updated May 18, 2017
• The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy

  NCT06815042

  Not yet recruitingInterventionalPhase 4Updated Feb 7, 2025